Numeta G19e (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numeta G19e is used in clinical nutrition to support patients who cannot meet their protein and caloric requirements through oral intake. It is indicated for:

• Pre‑term infants: supports growth and development during neonatal intensive care.
• Post‑surgical patients: aids recovery by providing essential amino acids.
• Critical‑illness patients: helps maintain nitrogen balance and muscle mass.
• Patients with malabsorption syndromes: supplies needed amino acids when gastrointestinal absorption is compromised.

• Numeta G19e delivers a balanced mixture of essential and conditionally essential amino acids directly into the bloodstream. The amino acids are taken up by cells and enter protein synthesis pathways, supporting tissue repair, enzyme production, and metabolic functions essential for patients receiving parenteral nutrition.

Numeta G19e may be associated with infusion‑related reactions and metabolic changes.

Common Side Effects

• Hyperglycaemia: elevated blood glucose levels during infusion.
• Electrolyte imbalance: shifts in potassium, sodium or calcium levels.
• Mild fever: low‑grade temperature rise during administration.
• Local irritation: redness or discomfort at the infusion site.
• Nausea: transient feeling of queasiness.
• Headache: mild headache during or after infusion.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical intervention.
• Sepsis: infection related to catheter use.
• Metabolic acidosis: significant drop in blood pH.
• Hyperosmolarity: high osmolar load causing vascular irritation.
• Thrombophlebitis: inflammation of the vein with clot formation.
• Renal impairment: worsening kidney function in susceptible patients.

Before using Numeta G19e, clinicians should assess patient suitability and monitor relevant parameters.

• Assess renal function: evaluate baseline creatinine and glomerular filtration rate.
• Monitor blood glucose: check glucose levels regularly during infusion.
• Check electrolytes: maintain potassium, sodium and calcium within target ranges.
• Observe infusion site: watch for signs of phlebitis or infiltration.
• Review medication history: identify potential allergens or contraindicated drugs.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Numeta G19e may interact with other intravenous solutions and medications administered concurrently.

Major Interactions (Avoid)

• High‑dose insulin: may exacerbate hypoglycaemia when combined with amino‑acid solutions.
• Potassium‑rich solutions: risk of hyperkalaemia if administered simultaneously.

Moderate Interactions (Monitor Closely)

• Diuretics: may alter electrolyte balance, requiring closer monitoring.
• Anticoagulants: potential impact on clotting parameters during infusion.
• Steroids: can affect glucose metabolism, increasing risk of hyperglycaemia.
• Calcium‑containing products: may precipitate when mixed with certain amino‑acid solutions.
• Other parenteral nutrition formulas: ensure compatibility before co‑administration.